SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-18-006740
Filing Date
2018-09-28
Accepted
2018-09-28 16:25:03
Documents
4
Period of Report
2018-10-30
Effectiveness Date
2018-09-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_092418.htm DEF 14A 713717
2 GRAPHIC logo.jpg GRAPHIC 3233
3 GRAPHIC proxycard_1.jpg GRAPHIC 77170
4 GRAPHIC proxycard_2.jpg GRAPHIC 50611
  Complete submission text file 0001171843-18-006740.txt   895658
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 181094468
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1